JNJ-928

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameJNJ-928
Drug Alias Nametankyrase 1/2 dual inhibitor (Janssen)JNJ-BJJNJ-928
ClassificationSmall molecules
Mechanisms of ActionAnticancer protein kinase inhibitorsTankyrase-1 inhibitorsTankyrase-2 inhibitors
TargetsTankyrase-1Tankyrase-2
Therapy Area/IndicationsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJanssen Pharmaceutica NV
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJanssen Pharmaceutica NV
Active IndicationsN/A
Inactive IndicationsLung Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A